REDHILL BIOPHARMA LTD (RDHLXXXX)
Institutional ownership reported to the SEC as of Q3 2024, across 24 quarters.
1
Reporting holders
$2
Reported value
0.0%
Held as options
-15
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| IFP Advisors, Inc | $2 | 7 | 0.00% | 7q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2024 | 1 | $2 | 7 | 0 | 0 | 0 | 0.0% |
| Q2 2024 | 16 | $705.7K | 1,904,139 | 3 | 3 | 5 | 0.0% |
| Q1 2024 | 15 | $1.4M | 2,626,941 | 2 | 6 | 1 | 0.0% |
| Q4 2023 | 19 | $473.5K | 308,919 | 4 | 7 | 1 | 5.0% |
| Q3 2023 | 19 | $780.4K | 1,513,313 | 4 | 3 | 6 | 1.1% |
| Q2 2023 | 20 | $426.4K | 338,339 | 6 | 3 | 3 | 4.7% |
| Q1 2023 | 17 | $1.2M | 270,632 | 17 | 0 | 0 | 5.8% |
| Q4 2022 | 30 | $1.3M | 8,844,992 | 7 | 6 | 9 | 1.1% |
| Q3 2022 | 39 | $1.5M | 2,913,622 | 4 | 15 | 8 | 2.8% |
| Q2 2022 | 47 | $4.0M | 4,172,632 | 4 | 12 | 15 | 2.3% |
| Q1 2022 | 45 | $12.4M | 4,721,478 | 3 | 14 | 15 | 4.3% |
| Q4 2021 | 53 | $15.3M | 4,980,919 | 13 | 13 | 18 | 16.0% |
| Q3 2021 | 57 | $28.9M | 5,333,012 | 15 | 15 | 14 | 15.4% |
| Q2 2021 | 55 | $55.0M | 7,134,575 | 7 | 17 | 14 | 10.8% |
| Q1 2021 | 66 | $82.9M | 10,593,051 | 12 | 22 | 18 | 6.6% |
| Q4 2020 | 64 | $71.7M | 8,110,735 | 13 | 22 | 13 | 8.5% |
| Q3 2020 | 54 | $82.7M | 7,606,069 | 16 | 19 | 7 | 6.1% |
| Q2 2020 | 45 | $48.8M | 7,062,561 | 5 | 21 | 9 | 3.1% |
| Q1 2020 | 48 | $28.2M | 6,197,041 | 9 | 17 | 8 | 0.2% |
| Q4 2019 | 44 | $39.7M | 6,517,428 | 9 | 10 | 9 | 0.3% |
| Q3 2019 | 39 | $57.0M | 8,065,835 | 7 | 6 | 10 | 0.4% |
| Q2 2019 | 36 | $54.0M | 8,279,684 | 4 | 4 | 11 | 0.4% |
| Q1 2019 | 37 | $64.9M | 7,796,144 | 3 | 8 | 14 | 0.2% |
| Q4 2018 | 39 | $46.1M | 8,284,348 | 2 | 2 | 1 | 0.2% |